This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AstraZenecas EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotecs allogeneic cell therapies are made by the in vivo reprogramming of a patients immune cells. The post AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition appeared first on MedCity News.
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isnt Intelligence in Healthcare appeared first on MedCity News.
Do you remember choosing between two types of COVID tests? PCR tests were highly accurate but took several days to get results. Meanwhile, antigen-based rapid tests offered results within minutes, but were far less accurate. In this week's episode, Stewart Gandolf speaks with Martin Price , CEO of HealthTrackRx , to explore how an innovative business model, leading-edge sales strategies, and game-changing partnerships has enabled HealthTrackRx to offer and scale next-morning PCR results nationwi
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented. The post Better Science, Better Medicine: How Clinical Research Advances Women’s Health appeared first on MedCity News.
Life is unpredictable. Its full of challenges that can hit when we least expect them. For me, one of those challenges came at the peak of my athletic career. At 19 years old, I was living my dream as a star wide receiver for Florida State University and a black-belt kickboxer. My last fight had even been televised on ESPN. But in a single, fateful moment, everything changed.
Life is unpredictable. Its full of challenges that can hit when we least expect them. For me, one of those challenges came at the peak of my athletic career. At 19 years old, I was living my dream as a star wide receiver for Florida State University and a black-belt kickboxer. My last fight had even been televised on ESPN. But in a single, fateful moment, everything changed.
Lantern has publicly released its methodology for calculating surgical savings, and is inviting others to do the same. The post Lantern Unveils Savings Methodology to Increase Transparency for Specialty Care Pricing appeared first on MedCity News.
Table of Contents Understanding the Importance of HCP Engagement in Pharma Marketing Key Marketing Strategies for Pharma Brands to Reach HCPs Optimizing Digital and Paid Media Strategies for Pharma Marketing Measuring Success: Tracking HCP Engagement and ROI Understanding the Importance of HCP Engagement in Pharma Marketing Engaging healthcare professionals (HCPs) effectively is a top priority for pharmaceutical brands.
Explore the concept of "uncertainty fatigue" and its profound impact on employees dealing with rapid workplace transformations, global events, and economic volatility. Understand the symptoms and consequences of this growing challenge and discover six practical strategies that leaders can implement to foster resilience, reduce stress, and enhance overall well-being in the workplace.
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Real-world intelligence is evident in the discussions taking place on social media. Social medias position in pharmaceutical research is further cemented by peoples growing usage of it.
The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, comments on how he envisions automation in the CAR-T manufacturing space playing a role in improving efficiency, reducing costs, and ultimately, expanding patient access.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology spoke with Peter Belden, president of Tjoapack US, ahead of DCAT Week 2025 to discuss recent innovations in bio/pharmaceutical packaging.
As part of our coverage of this years DCAT Week, Pharmaceutical Technology spoke with Hamilton Lenox, chief commercial officer at LGM Pharma about the expanding pharma market and the challenges such demand creates.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, off-the-shelf novel formulations for b2b licensing.
While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data integrity requires expertise and in-country support services.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
274 
Let's personalize your content